Error: Could not add to watchlist. X
+ Watchlist

Verastem Inc

VSTM:US
NASDAQ GM
2.34
USD
0.04
1.57%
As of 2:04 PM EDT 6/23/2017
Open
2.38
Day Range
2.33 - 2.39
Volume
160,599
Previous Close
2.38
52Wk Range
1.05 - 2.54
1 Yr Return
74.82%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
2.38
Day Range
2.33 - 2.39
Volume
160,599
Previous Close
2.38
52Wk Range
1.05 - 2.54
1 Yr Return
74.82%
YTD Return
109.16%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.09
Market Cap (m USD)
87.302
Shares Outstanding (m)
36.992
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.27%
% Price Change
-0.33%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Verastem Inc., is a clinical biopharmaceutical company. The Company focuses on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Verastem also develops proprietary companion diagnostics for stem cells. The Company's technology allows the creation of stable programs for various signaling pathways.
Address
215 First Street
Suite 440
Cambridge, MA 02142
United States
Phone
1-617-858-0338
  • Robert Forrester
    President/CEO
  • Joe Chiapponi
    CFO/Chief Acctg Ofcr/Treasurer
  • Daniel Paterson
    Chief Operating Officer
  • Jonathan Pachter
    Chief Scientific Officer
  • Monica Kleinman
    VP/General Counsel
Show More